Compounds > beta-lactams
Page last updated: 2024-09-04

beta-lactams and Shock, Septic

beta-lactams has been researched along with Shock, Septic in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (21.43)29.6817
2010's13 (46.43)24.3611
2020's9 (32.14)2.80

Authors

AuthorsStudies
Abruzzi, J; Kopczynski, A; Montes, THM; Nedel, WL; Portela, LV; Rodolphi, MS; Strogulski, NR1
Du, J; Mao, Y; Pang, M; Wang, H; Wu, D; Xu, N; Yan, M; Zhang, X1
Atkinson, A; Damulira, C; Fraser, VJ; Guillamet, MCV; Kollef, MH; Micek, S1
Batteux, B; Bennis, Y; Bodeau, S; Gaulin, C; Kontar, L; Lemaire-Hurtel, AS; Maizel, J; Zerbib, Y1
Cobian, J; Hall, B; Miller, J; Wilson, K1
Delattre, IK; Dugernier, T; Hites, M; Jacobs, F; Laterre, PF; Spapen, H; Taccone, FS; Wallemacq, PE1
Hughes, RE; Judd, WR; Komyathy, KL; Ratliff, PD1
Marsot, A1
Anderson, WE; Hammer, J; Heffner, AC; Jaffa, RK; Medaris, LA; Pillinger, KE1
Castegren, M; Furebring, M; Lipcsey, M; Sjölin, J1
Bernhard, M; Brenner, T; Briegel, J; Brinkmann, A; Dubler, S; Grabein, B; Hecker, A; Heininger, A; Hochreiter, M; Hoppe-Tichy, T; Kruger, WA; Lichtenstern, C; Mayer, K; Pinder, N; Pletz, MW; Richter, DC; Storzinger, D; Weigand, MA; Weiterer, S; Zimmermann, S1
Hampton, N; Kollef, MH; Micek, ST; Teshome, BF; Vouri, SM1
Calvo, G; Llauradó-Serra, M; Martín-Loeches, I; Pontes, C; Soy, D; Ulldemolins, M; Vaquer, S1
Roberts, DM; Roberts, JA1
Adam, R; Michels, G; Müller, C; Nosseir, NS; Pfister, R; Wiesen, MH1
Chowers, M; Krashin, E; Lishner, M; Reisfeld, S1
Falagas, ME; Trigkidis, KK; Vardakas, KZ1
Fernández, L; Gómez-Rice, A; Lillo, M; Maseda, E; Ramasco, F; Villagrán, MJ1
De Backer, D; Delattre, I; Dugernier, T; Jacobs, F; Laterre, PF; Layeux, B; Spapen, H; Taccone, FS; Vincent, JL; Wallemacq, P; Wittebole, X1
Cotton, F; De Backer, D; Jacobs, F; Macours, P; Seyler, L; Taccone, FS; Vincent, JL1
Ferrer, R; González de Molina, FJ1
Beumier, M; Cotton, F; De Backer, D; Hites, M; Jacobs, F; Lorent, S; Roisin, S; Seyler, L; Surin, R; Taccone, FS; Vincent, JL; Wolff, F1
Artigas, A; Díaz-Martín, A; Ferrer, R; Garnacho-Montero, J; Levy, MM; Lopez-Pueyo, MJ; Martín-Loeches, I; Martínez-González, ML; Ortiz-Leyba, C; Piacentini, E1
Bruun, NE; Mellerup, MT; Nielsen, JD1
Chapman, AL; Greig, JM; Innes, JA1
Barra, D; Bozzi, A; Cirioni, O; Di Giulio, A; Ghiselli, R; Giacometti, A; Luzi, C; Mangoni, ML; Mocchegiani, F; Orlando, F; Rinaldi, AC; Saba, V; Scalise, G; Silvestri, C1
Cirioni, O; Della Vittoria, A; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C1
Almanasreh, N; Andreassen, S; Cauda, R; Frank, U; Gafter-Gvili, A; Goldberg, E; Leibovici, L; Nielsen, AD; Paul, M; Tacconelli, E1

Reviews

5 review(s) available for beta-lactams and Shock, Septic

ArticleYear
Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children?
    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2020, Volume: 23

    Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Models, Biological; Sepsis; Severity of Illness Index; Shock, Septic; Young Adult

2020
Bacterial sepsis : Diagnostics and calculated antibiotic therapy.
    Der Anaesthesist, 2019, Volume: 68, Issue:Suppl 1

    Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; beta-Lactams; Biomarkers; Drug Monitoring; Humans; Intensive Care Units; Shock, Septic

2019
Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.
    Critical care (London, England), 2014, Jun-23, Volume: 18, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Critical Illness; Humans; Meropenem; Piperacillin; Renal Replacement Therapy; Shock, Septic; Thienamycins

2014
[Therapeutic Drug Monitoring of antiinfectives in intensive care medicine].
    Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139, Issue:38

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Biological Availability; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Fluoroquinolones; Guideline Adherence; Humans; Intensive Care Units; Linezolid; Metabolic Clearance Rate; Microbial Sensitivity Tests; Oxazolidinones; Sepsis; Shock, Septic; Teicoplanin; Vancomycin

2014
Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2017, Volume: 23, Issue:4

    Topics: Adult; Bacteremia; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Fluoroquinolones; Hospitalization; Humans; Macrolides; Odds Ratio; Pneumonia, Bacterial; Shock, Septic; Treatment Outcome

2017

Trials

2 trial(s) available for beta-lactams and Shock, Septic

ArticleYear
[Septic shock due to community-acquired complicated intra-abdominal infection treated with ertapenem: outcome in 25 cases].
    Revista espanola de anestesiologia y reanimacion, 2008, Volume: 55, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Community-Acquired Infections; Critical Care; Emergencies; Ertapenem; Female; Hospital Mortality; Humans; Intestinal Perforation; Length of Stay; Male; Middle Aged; Peritonitis; Prospective Studies; Shock, Septic; Survival Analysis; Treatment Outcome

2008
The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis.
    The European respiratory journal, 2007, Volume: 30, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Decision Support Techniques; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Length of Stay; Macrolides; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Pneumonia, Bacterial; Probability; Prospective Studies; Severity of Illness Index; Shock, Septic; Survival Analysis; Survival Rate

2007

Other Studies

21 other study(ies) available for beta-lactams and Shock, Septic

ArticleYear
Antibiotic therapy does not alter mitochondrial bioenergetics in lymphocytes of patients with septic shock - A prospective cohort study.
    Mitochondrion, 2022, Volume: 66

    Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clavulanic Acid; Energy Metabolism; Humans; Lymphocytes; Meropenem; Mitochondria; Piperacillin, Tazobactam Drug Combination; Polymyxins; Prospective Studies; Shock, Septic; Vancomycin

2022
Factors associated with the decision to administer β-lactams via prolonged infusion in patients with sepsis: a prospective observational cohort study.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 124

    Topics: beta-Lactams; Cohort Studies; Humans; Prospective Studies; Sepsis; Shock, Septic

2022
Addition of aminoglycosides reduces recurrence of infections with multidrug-resistant Gram-negative bacilli in patients with sepsis and septic shock.
    International journal of antimicrobial agents, 2023, Volume: 62, Issue:4

    Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Retrospective Studies; Sepsis; Shock, Septic

2023
Neurological burden and outcomes of excessive β-lactam serum concentrations of critically ill septic patients: a prospective cohort study.
    The Journal of antimicrobial chemotherapy, 2023, 11-06, Volume: 78, Issue:11

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Humans; Male; Prospective Studies; Shock, Septic

2023
Impact of SEP-1 on broad-spectrum combination antibiotic therapy in the emergency department.
    The American journal of emergency medicine, 2020, Volume: 38, Issue:12

    Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Centers for Medicare and Medicaid Services, U.S.; Early Diagnosis; Early Medical Intervention; Emergency Service, Hospital; Female; Guideline Adherence; Hospital Mortality; Hospitalization; Humans; Male; Medical Overuse; Meropenem; Middle Aged; Patient Care Bundles; Piperacillin, Tazobactam Drug Combination; Reimbursement Mechanisms; Retrospective Studies; Sepsis; Shock, Septic; Soft Tissue Infections; Time-to-Treatment; United States; Urinary Tract Infections; Vancomycin

2020
What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from pharmacokinetic simulation modelling.
    International journal of antimicrobial agents, 2020, Volume: 56, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Computer Simulation; Humans; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Shock, Septic

2020
Assessing mortality outcomes of beta-lactam-allergic patients presenting with sepsis.
    The American journal of emergency medicine, 2020, Volume: 38, Issue:9

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Drug Hypersensitivity; Female; Hospital Mortality; Humans; Kentucky; Male; Middle Aged; Retrospective Studies; Shock, Septic

2020
Empiric aztreonam is associated with increased mortality compared to beta-lactams in septic shock.
    The American journal of emergency medicine, 2021, Volume: 48

    Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; APACHE; Aztreonam; beta-Lactams; Cefepime; Cohort Studies; Drug Hypersensitivity; Female; Fluoroquinolones; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Shock, Septic

2021
Should the Aminoglycoside β-Lactam Combination Be Abandoned in All Severely Ill Patients With Presumed Gram-Negative Infection?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 01-18, Volume: 66, Issue:3

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Gentamicins; Humans; Prospective Studies; Shock, Septic

2018
Duration of Exposure to Antipseudomonal β-Lactam Antibiotics in the Critically Ill and Development of New Resistance.
    Pharmacotherapy, 2019, Volume: 39, Issue:3

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Shock, Septic; Tertiary Care Centers; Time Factors

2019
Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines?
    Critical care (London, England), 2014, Jun-23, Volume: 18, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Humans; Renal Replacement Therapy; Shock, Septic

2014
Candida albicans in peritoneal fluid in a patient with hepatic encephalopathy.
    The Israel Medical Association journal : IMAJ, 2014, Volume: 16, Issue:12

    Topics: Administration, Intravenous; Anti-Bacterial Agents; Antifungal Agents; Ascites; Ascitic Fluid; beta-Lactams; Candida albicans; Ertapenem; Escherichia coli; Escherichia coli Infections; Fatal Outcome; Female; Fluconazole; Hepatic Encephalopathy; Hepatitis C; Humans; Liver Cirrhosis; Middle Aged; Paracentesis; Shock, Septic

2014
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
    Critical care (London, England), 2010, Volume: 14, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Sepsis; Shock, Septic; Tazobactam; Thienamycins

2010
Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy.
    Critical care (London, England), 2011, Volume: 15, Issue:3

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Dose-Response Relationship, Drug; Female; Humans; Intensive Care Units; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Prospective Studies; Pseudomonas aeruginosa; Renal Replacement Therapy; Shock, Septic; Thienamycins

2011
Appropriate antibiotic dosing in severe sepsis and acute renal failure: factors to consider.
    Critical care (London, England), 2011, Aug-01, Volume: 15, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Female; Humans; Male; Renal Replacement Therapy; Shock, Septic

2011
Case-control study of drug monitoring of β-lactams in obese critically ill patients.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Cefepime; Ceftazidime; Cephalosporins; Drug Monitoring; Enzyme Inhibitors; Female; Humans; Male; Meropenem; Middle Aged; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Replacement Therapy; Sepsis; Shock, Septic; Tazobactam; Thienamycins; Young Adult

2013
Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality.
    Critical care (London, England), 2012, Nov-18, Volume: 16, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Practice Patterns, Physicians'; Sepsis; Shock, Septic; Spain; Treatment Outcome

2012
[Increased bleeding tendency induced by beta-lactam antibiotics].
    Ugeskrift for laeger, 2005, Jun-20, Volume: 167, Issue:25-31

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Endocarditis, Bacterial; Gentamicins; Hemorrhage; Humans; Male; Middle Aged; Penicillins; Shock, Septic

2005
MRSA in the community.
    The New England journal of medicine, 2005, Aug-04, Volume: 353, Issue:5

    Topics: Adolescent; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Community-Acquired Infections; Enterotoxins; Female; Humans; Methicillin Resistance; Risk Factors; Shock, Septic; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Vancomycin

2005
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:7

    Topics: Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; beta-Lactams; Disease Models, Animal; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Lipopolysaccharides; Male; Microbial Sensitivity Tests; Peritonitis; Piperacillin; Proteins; Rats; Rats, Wistar; Shock, Septic

2006
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock.
    Shock (Augusta, Ga.), 2006, Volume: 26, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactams; Cathelicidins; Cecum; Disease Models, Animal; Drug Synergism; Endotoxins; Enterococcus faecalis; Ertapenem; Escherichia coli; Escherichia coli Infections; Interleukin-6; Ligation; Male; Microbial Sensitivity Tests; Oligopeptides; Rats; Rats, Wistar; Shock, Septic; Tumor Necrosis Factor-alpha

2006